Raymond James & Associates’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$301K Sell
32,780
-5,461
-14% -$50.1K ﹤0.01% 3379
2024
Q2
$374K Sell
38,241
-3,114
-8% -$30.5K ﹤0.01% 3219
2024
Q1
$624K Sell
41,355
-134,255
-76% -$2.03M ﹤0.01% 2898
2023
Q4
$3.78M Sell
175,610
-52,628
-23% -$1.13M ﹤0.01% 1704
2023
Q3
$4.24M Buy
228,238
+2,029
+0.9% +$37.7K ﹤0.01% 1558
2023
Q2
$5.73M Buy
226,209
+6,907
+3% +$175K ﹤0.01% 1387
2023
Q1
$5.68M Buy
219,302
+11,926
+6% +$309K ﹤0.01% 1380
2022
Q4
$4.9M Sell
207,376
-16,126
-7% -$381K ﹤0.01% 1411
2022
Q3
$5.67M Buy
223,502
+432
+0.2% +$11K 0.01% 1286
2022
Q2
$7.41M Sell
223,070
-12,126
-5% -$403K 0.01% 1152
2022
Q1
$17M Buy
235,196
+13,018
+6% +$939K 0.01% 779
2021
Q4
$20.4M Sell
222,178
-22,241
-9% -$2.04M 0.02% 734
2021
Q3
$31M Sell
244,419
-5,049
-2% -$640K 0.03% 515
2021
Q2
$41.5M Sell
249,468
-12,009
-5% -$2M 0.04% 411
2021
Q1
$47.5M Sell
261,477
-21,727
-8% -$3.95M 0.05% 334
2020
Q4
$56.6M Buy
283,204
+1,385
+0.5% +$277K 0.06% 259
2020
Q3
$61.8M Buy
281,819
+22,996
+9% +$5.04M 0.08% 208
2020
Q2
$49.4M Buy
258,823
+16,711
+7% +$3.19M 0.07% 245
2020
Q1
$37.5M Sell
242,112
-482
-0.2% -$74.7K 0.06% 261
2019
Q4
$20.3M Sell
242,594
-4,993
-2% -$418K 0.03% 574
2019
Q3
$16.8M Buy
247,587
+11,777
+5% +$798K 0.02% 619
2019
Q2
$15.7M Buy
235,810
+22,078
+10% +$1.47M 0.02% 639
2019
Q1
$11.9M Buy
213,732
+29,746
+16% +$1.65M 0.02% 727
2018
Q4
$9.12M Sell
183,986
-33,291
-15% -$1.65M 0.02% 796
2018
Q3
$18.8M Sell
217,277
-10,956
-5% -$946K 0.03% 556
2018
Q2
$13.2M Buy
228,233
+5,777
+3% +$335K 0.02% 678
2018
Q1
$8.97M Buy
222,456
+106,743
+92% +$4.3M 0.02% 840
2017
Q4
$4.03M Buy
115,713
+3,589
+3% +$125K 0.01% 1246
2017
Q3
$3.72M Buy
112,124
+52,507
+88% +$1.74M 0.01% 1245
2017
Q2
$2.07M Buy
59,617
+9,345
+19% +$324K ﹤0.01% 1554
2017
Q1
$1.26M Buy
+50,272
New +$1.26M ﹤0.01% 1827